Cargando…
Bringing a Gene-Activated Bone Substitute Into Clinical Practice: From Bench to Bedside
Bone grafting and reconstruction are still challenging in clinical practice because of the limitations of bone autografts and the drawbacks of currently approved bone substitutes. We thus developed a gene-activated bone substitute based on octacalcium phosphate and naked plasmid DNA carrying the vas...
Autores principales: | Bozo, Ilia Y., Drobyshev, Alexey Y., Redko, Nikolay A., Komlev, Vladimir S., Isaev, Artur A., Deev, Roman V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889956/ https://www.ncbi.nlm.nih.gov/pubmed/33614609 http://dx.doi.org/10.3389/fbioe.2021.599300 |
Ejemplares similares
-
3D Printing of Octacalcium Phosphate Bone Substitutes
por: Komlev, Vladimir S., et al.
Publicado: (2015) -
World's First Clinical Case of Gene-Activated Bone Substitute Application
por: Bozo, I. Y., et al.
Publicado: (2016) -
The Few Who Made It: Commercially and Clinically Successful Innovative Bone Grafts
por: Sallent, Ignacio, et al.
Publicado: (2020) -
Ordinary and Activated Bone Grafts: Applied Classification and the Main Features
por: Deev, R. V., et al.
Publicado: (2015) -
Systematic Review of the Preclinical Technology Readiness of Orthopedic Gene Therapy and Outlook for Clinical Translation
por: Wilkinson, Piers, et al.
Publicado: (2021)